Why is Windlas Biotech falling/rising?

As of 22-Sep, Windlas Biotech Ltd is experiencing a decline in its stock price, currently at Rs 945.30, which reflects a decrease of Rs 17.55 or 1.82%. The stock has underperformed its sector today by 0.74%, touching an intraday low of Rs 943, which is a drop of 2.06%. Additionally, Windlas Biotech is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. Over the past week, the stock has decreased by 5.47%, and over the past month, it has fallen by 6.77%. Despite a positive performance over the last year, with a return of 9.64%, the stock's recent performance is overshadowed by a significant drop in investor participation, with delivery volume decreasing by 22.77% against the 5-day average.
In the broader market context, Windlas Biotech's short-term performance is notably worse than the Sensex, which has gained 0.46% over the past week and 1.05% over the past month. This underperformance is compounded by the company's current valuation metrics, where it is trading at a premium compared to its peers, despite a low debt-to-equity ratio and consistent returns over the last three years. While the company reported positive quarterly results, including record net sales and profits, the high PEG ratio of 3.6 suggests that the stock may be overvalued relative to its growth prospects, contributing to the recent price decline.